Showing results (61-70 of 175) with videos related to

Sort By:
Pageof 18
American Journal of Clinical Oncology|February 1, 1995
A phase II trial of 5-fluorouracil and high-dose leucovorin in recurrent epithelial ovarian carcinoma. A Gynecologic Oncology Group StudyK Y Look, H B Muss, J A Blessing, et al.
American Journal of Clinical Oncology|August 26, 1998
A phase II trial of amonafide in patients with endometrial cancer: a Gynecologic Oncology Group StudyR Asbury, J A Blessing, G C Reid, et al.
Gynecologic Oncology|March 1, 1986
Phase II trials of cisplatin and piperazinedione in advanced or recurrent squamous cell carcinoma of the vulva: a Gynecologic Oncology Group StudyJ T Thigpen, J A Blessing, H D Homesley, et al.
Investigational New Drugs|April 9, 2001
A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix--a Gynecologic Oncology Group StudyS C Plaxe, J A Blessing, J A Lucci, et al.
Gynecologic Oncology|February 1, 1994
Phase II trial of menogaril in patients with squamous carcinoma of the cervix: a Gynecologic Oncology Group studyG P Sutton, J A Blessing, R J Barrett, et al.
Seminars in Oncology|December 1, 1992
Gynecologic Oncology Group studies with ifosfamideG P Sutton, J A Blessing, A Manetta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1991
Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology GroupS D Williams, J A Blessing, K D Hatch, et al.
Cancer Treatment Reports|February 1, 1986
Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group StudyJ T Thigpen, J A Blessing, J W Orr, et al.
Gynecologic Oncology|June 28, 2001
Evaluation of recombinant human interleukin-12 in patients with recurrent or refractory ovarian cancer: a gynecologic oncology group studyJ A Hurteau, J A Blessing, S L DeCesare, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology GroupS Williams, J A Blessing, S Y Liao, et al.
Pageof 18